Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Dyslipidemia is an independent risk factor for type 2 diabetes, although exactly which of the many plasma lipids contribute to this remains unclear. We therefore investigated whether lipid profiling can inform diabetes prediction by performing liquid chromatography/mass spectrometry-based lipid profiling in 189 individuals who developed type 2 diabetes and 189 matched disease-free individuals, with over 12 years of follow up in the Framingham Heart Study. We found that lipids of lower carbon number and double bond content were associated with an increased risk of diabetes, whereas lipids of higher carbon number and double bond content were associated with decreased risk. This pattern was strongest for triacylglycerols (TAGs) and persisted after multivariable adjustment for age, sex, BMI, fasting glucose, fasting insulin, total triglycerides, and HDL cholesterol. A combination of 2 TAGs further improved diabetes prediction. To explore potential mechanisms that modulate the distribution of plasma lipids, we performed lipid profiling during oral glucose tolerance testing, pharmacologic interventions, and acute exercise testing. Levels of TAGs associated with increased risk for diabetes decreased in response to insulin action and were elevated in the setting of insulin resistance. Conversely, levels of TAGs associated with decreased diabetes risk rose in response to insulin and were poorly correlated with insulin resistance. These studies identify a relationship between lipid acyl chain content and diabetes risk and demonstrate how lipid profiling could aid in clinical risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, specific TAGs containing palmitate or stearate, i.e. TAG 48:0, 50:0, 48:1 and 50:1, have been associated with the severity of MASLD and with an increased risk of developing T2D.105,106”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES
Nakamura, M. T., & Nara, T. Y. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.121803.063211 · Cited by 1,073
Guillou, H., Zadravec, D., Martin, P. G. P., & Jacobsson, A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.002 · Cited by 865
Invited Review: Effects of acute exercise and exercise training on insulin resistance
Henriksen, E. J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2001 · Cited by 535
Research works printed but not linked: 1
- German, 2007, Curr Opin Lipidol., 18, 66
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Human gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
“Interestingly, a similar TAG profile has been found (in large cohort studies) to be present in individuals who have acquired insulin resistance (393).”
BackgroundInfluentialMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
“Similar observations have recently been reported for fatty acid compositions of erythrocyte membrane phospholipids (54) and triglycerides (55), suggesting that lipids with a shorter chain length and saturated fatty acid residues may trigger development of T2D, whereas those containing longer chains and unsaturated fat…”
ResultMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
“Authors concluded that lipids of lower carbon number and lower double-bond content, especially triacylglycerols (TAGs), were associatedwith higher risk of prediabetes and type 2 diabetes, while those with higher carbon number and more double bondswere associatedwith lower risk (9).”
BackgroundInfluentialSelf-citationSoininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects
Yore, M. M., Syed, I., Moraes-Vieira, P. M., Zhang, T., Herman, M. A., Homan, E. A., Patel, R. T., Lee, J., Chen, S., Peroni, O. D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.035 · Cited by 842
“The major pathogenic factors underlying T2D are resistance to insulin action in peripheral tissues and dysregulated insulin secretion.”
BackgroundInfluentialMetabolomics and Metabolic Diseases: Where Do We Stand?
Newgard, C. B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.018 · Cited by 750
Metabolomics: an emerging but powerful tool for precision medicine
Clish, C. B. (2015) · Molecular Case Studies · doi:10.1101/mcs.a000588 · Cited by 708
“…find early metabolic indicators of disease in longitudinal cohorts years before symptoms are clinically apparent—for example, in pancreatic cancer (Mayers et al. 2014), type 2 diabetes (Rhee et al. 2011, Wang et al. 2011; 2013), memory impairment (Mapstone et al. 2014), and many other conditions.”
BackgroundSelf-citationNovel biomarkers for pre-diabetes identified by metabolomics
Wang‐Sattler, R., Yu, Z., Herder, C., Messias, A. C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.43 · Cited by 701
Würtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., Ghorbani, A., Artati, A., Wang, Q., Tiainen, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013116 · Cited by 677
Self-citationComprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry
Cajka, T., & Fiehn, O. (2014) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2014.04.017 · Cited by 650
“[80] presented a comprehensive LC-MS analysis of the natural variation in the Arabidopsis thaliana lipidome and of the effects of cold acclimation in relation to leaf freezing tolerance.”
BackgroundStegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.002500 · Cited by 564
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
“Among these lipids, increased intracellular concentrations of TG, diacylglycerols (DAG), glycerophosphocholine (GPC), phosphocholines (PC), ceramides and sphingomyelin have been implicated in the development of metabolic diseases including diabetes and non-alcoholic fatty liver disease [99,138–147].”
BackgroundSequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
The SIGMA Type 2 Diabetes Consortium (2014) · Nature · doi:10.1038/nature12828 · Cited by 507
Self-citationNew insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
2-Aminoadipic acid is a biomarker for diabetes risk
Wang, T. J., Ngo, D., Psychogios, N., Dejam, A., Larson, M. G., Vasan, R. S., Ghorbani, A., O’Sullivan, J., Cheng, S., Rhee, E. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64801 · Cited by 452
“The purpose of this approach was to provide coverage of metabolites not amenable to previously described approaches (8, 9), though limited coverage of the human metabolome remains a limitation of our studies.”
BackgroundMethodSelf-citationMetabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002179 · Cited by 417
Menni, C., Fauman, E., Erte, I., Perry, J. R. B., Kastenmüller, G., Shin, S.-Y., Petersen, A.-K., Hyde, C., Psatha, M., Ward, K. J., et al. (2013) · Diabetes · doi:10.2337/db13-0570 · Cited by 416
“found that triglycerides containing longer chain fatty acids were associated with a decreased risk of diabetes, while triglycerides containing shorter chains were associated with an increased risk (9).”
BackgroundPlasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes
Barber, M. N., Risis, S., Yang, C., Meikle, P. J., Staples, M., Febbraio, M. A., & Bruce, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041456 · Cited by 370
“Although contrasting the reports of increased circulating LPC in obesity [6] and T2DM [23], these results are consistent with those of others who found that plasma LPCs were diminished in glucose intolerant and insulin resistant individuals [4,7,21].”
ResultFlavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Miao, J., Ling, A. V., Manthena, P. V., Gearing, M. E., Graham, M. J., Crooke, R. M., Croce, K. J., Esquejo, R. M., Clish, C. B., Morbid Obesity Study Group, et al. (2015) · Nature Communications · doi:10.1038/ncomms7498 · Cited by 368
Self-citationPlasma lipid profiling in a large population-based cohort
Weir, J. M., Wong, G., Barlow, C. K., Greeve, M. A., Kowalczyk, A., Almasy, L., Comuzzie, A. G., Mahaney, M. C., Jowett, J. B. M., Shaw, J., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p035808 · Cited by 366
Wang, D. D., Toledo, E., Hruby, A., Rosner, B. A., Willett, W. C., Sun, Q., Razquin, C., Zheng, Y., Ruiz-Canela, M., Guasch-Ferré, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024261 · Cited by 327
Self-citationA Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort
Rhee, E. P., Ho, J. E., Chen, M.-H., Shen, D., Cheng, S., Larson, M. G., Ghorbani, A., Shi, X., Helenius, I. T., O’Donnell, C. J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.013 · Cited by 321
“, plasma lipoprotein triglyceride content) (Rhee et al., 2011).”
InfluentialSelf-citationA Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101006 · Cited by 307
Self-citationMetabolic Signatures of Insulin Resistance in 7,098 Young Adults
Würtz, P., Mäkinen, V.-P., Soininen, P., Kangas, A. J., Tukiainen, T., Kettunen, J., Savolainen, M. J., Tammelin, T., Viikari, J. S., Rönnemaa, T., et al. (2012) · Diabetes · doi:10.2337/db11-1355 · Cited by 308
“In the same study population, comprehensive lipid profiling demonstrated that fatty acids of shorter carbon chain length and lower double bond content were associated with insulin resistance index and an increased risk of diabetes (11).”
BackgroundResultInfluentialMorze, J., Wittenbecher, C., Schwingshackl, L., Danielewicz, A., Rynkiewicz, A., Hu, F. B., & Guasch-Ferré, M. (2022) · Diabetes Care · doi:10.2337/dc21-1705 · Cited by 298
Defining the Metabolome: Size, Flux, and Regulation
Zamboni, N., Saghatelian, A., & Patti, G. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.021 · Cited by 300
“…the aforementioned studies, additional work has utilizedmetabolomics to studymetabolic disease, such asmetabolic risk factors for type 2 diabetes (Rhee et al., 2011; Wang et al., 2013) and the identification of metabolically beneficial lipids (Cao et al., 2008; Oh et al., 2010), including novel…”
The ins and outs of endoplasmic reticulum‐controlled lipid biosynthesis
Jacquemyn, J., Cascalho, A., & Goodchild, R. E. (2017) · EMBO reports · doi:10.15252/embr.201643426 · Cited by 286
“…parallel with restoring normal hepatic ER membrane composition [120], clinical data correlate specific acyl chain TAG profiles with type 2 diabetes [127], and genetically reducing lipin degradation in mice (thereby allowing SREBP suppression) reduces high-fat-diet liver pathology and circulating…”
Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
“It is also relevant that circulating triglycerides with lower carbon number and double bonds are associated with insulin resistance and epidemiologically with increased diabetes risk (350); it is unclear whether this is a causative relationship, but it is possible that corresponding triglyceride-derived DAGs or cerami…”
BackgroundPalaniappan, L. P., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 242
Alshehry, Z. H., Mundra, P. A., Barlow, C. K., Mellett, N. A., Wong, G., McConville, M. J., Simes, J., Tonkin, A. M., Sullivan, D. R., Barnes, E. H., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023233 · Cited by 268
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Roberts, L. D., Koulman, A., & Griffin, J. L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70143-8 · Cited by 263
Metabolomics of type 1 and type 2 diabetes
Arneth, B., Arneth, R., & Shams, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102467 · Cited by 262
New perspectives in diabetic neuropathy
Eid, S. A., Rumora, A. E., Beirowski, B., Bennett, D. L., Hur, J., Savelieff, M. G., & Feldman, E. L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.003 · Cited by 257
Willeit, P., Skroblin, P., Moschen, A. R., Yin, X., Kaudewitz, D., Zampetaki, A., Barwari, T., Whitehead, M., Ramírez, C. M., Goedeke, L., et al. (2017) · Diabetes · doi:10.2337/db16-0731 · Cited by 255
“We and others have previously shown that these lipid subspecies, comprised of saturated and monounsaturated fatty acids, are associated with a higher risk of CVD (9) and T2D (33).”
BackgroundXuan, Q., Hu, C., Yu, D., Wang, L., Zhou, Y., Zhao, X., Li, Q., Hou, X., & Xu, G. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01331 · Cited by 244
Reproducibility of Metabolomic Profiles among Men and Women in 2 Large Cohort Studies
Townsend, M. K., Clish, C. B., Kraft, P., Wu, C., Souza, A. L., Deik, A. A., Tworoger, S. S., & Wolpin, B. M. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.199133 · Cited by 242
Self-citationDiet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites
Fujisaka, S., Avila-Pacheco, J., Soto, M., Kostic, A., Dreyfuss, J. M., Pan, H., Ussar, S., Altindis, E., Li, N., Bry, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.060 · Cited by 231
“…and N-acetylglycine have also been previously identified in humans as potential biomarkers for diabetes risk and insulin resistance (Gall et al., 2010; Menni et al., 2013; Wang et al., 2013), as have patterns of lipids with lower fatty acyl carbon number and double bond content (Rhee et al., 2011).”
BackgroundSelf-citationSGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms
Osataphan, S., Macchi, C., Singhal, G., Chimene-Weiss, J., Sales, V., Kozuka, C., Dreyfuss, J. M., Pan, H., Tangcharoenpaisan, Y., Morningstar, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123130 · Cited by 228
“This pattern, which was unique to CANA and not observed in WM mice, is similar to the serum triglyceride composition previously linked to metabolic health and decreased progression from impaired fasting glucose to T2D in humans (23).”
ResultSelf-citationMeasuring the exposome: A powerful basis for evaluating environmental exposures and cancer risk
Wild, C. P., Scalbert, A., & Herceg, Z. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21777 · Cited by 227
Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
Sangwung, P., Petersen, K. F., Shulman, G. I., & Knowles, J. W. (2020) · Endocrinology · doi:10.1210/endocr/bqaa017 · Cited by 218
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes
Russo, S. B., Baicu, C. F., Van Laer, A., Geng, T., Kasiganesan, H., Zile, M. R., & Cowart, L. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63888 · Cited by 211
“Because of these weaknesses in present model systems, our laboratory recently implemented a new obesogenic high-fat diet that was designed to replicate the shift toward shorter SFAs observed in the plasma of obese and diabetic patients (13).”
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
Proitsi, P., Kim, M., Whiley, L., Simmons, A., Sattlecker, M., Velayudhan, L., Lupton, M. K., Soininen, H., Kloszewska, I., Mecocci, P., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.003 · Cited by 209
Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
Razquin, C., Toledo, E., Clish, C. B., Ruiz-Canela, M., Dennis, C., Corella, D., Papandreou, C., Ros, E., Estruch, R., Guasch-Ferré, M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0840 · Cited by 208
“Higher circulating levels of DAG and short TAGs have been previously associated with T2D (6,31).”
BackgroundResultSelf-citationMetabolomics and Proteomics in Type 2 Diabetes
Chen, Z.-Z., & Gerszten, R. E. (2020) · Circulation Research · doi:10.1161/circresaha.120.315898 · Cited by 204
Self-citationCirculating Metabolite Predictors of Glycemia in Middle-Aged Men and Women
Würtz, P., Tiainen, M., Mäkinen, V.-P., Kangas, A. J., Soininen, P., Saltevo, J., Keinänen-Kiukaanniemi, S., Mäntyselkä, P., Lehtimäki, T., Laakso, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1838 · Cited by 203
“Comprehensive lipid profiling was recently used to identify a pattern of triacylglycerides associated with insulin resistance and the risk for future diabetes (8).”
Novel methodologies for biomarker discovery in atherosclerosis
Hoefer, I. E., Steffens, S., Ala-Korpela, M., Bäck, M., Badimon, L., Bochaton-Piallat, M.-L., Boulanger, C. M., Caligiuri, G., Dimmeler, S., Egido, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv236 · Cited by 200
“A similar fatty acid chain length shift has previously been linked to the risk of type 2 diabetes.(163) The top scoring lipids significantly improved the risk discrimination for cardiovascular disease during a 10-year follow-up, hence providing a first piece of evidence for a predictive value of circulating biomarker…”
Review of methods for detecting glycemic disorders
Bergman, M., Abdul-Ghani, M., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M., Phillips, L. S., Chung, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108233 · Cited by 199
“Plasma triacylglycerols with lower carbon number and double-bond content have been associated with an increased risk of T2D whereas those with higher carbon number and double bonds were associated with decreased risk [255,256].”
BackgroundInterorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S., Chen, M.-H., Keyes, M., Rhee, E. P., Clish, C. B., Vasan, R. S., Gerszten, R. E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148361 · Cited by 188
Self-citationImpaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD
Afshinnia, F., Rajendiran, T. M., Soni, T., Byun, J., Wernisch, S., Sas, K. M., Hawkins, J., Bellovich, K., Gipson, D., Michailidis, G., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030350 · Cited by 183
Tonks, K. T., Coster, A. C., Christopher, M. J., Chaudhuri, R., Xu, A., Gagnon‐Bartsch, J., Chisholm, D. J., James, D. E., Meikle, P. J., Greenfield, J. R., et al. (2016) · Obesity · doi:10.1002/oby.21448 · Cited by 180
“Large cohort studies, including studies from our group, have highlighted the strong potential of plasma lipidomics in explaining metabolic disease when added to traditional disease markers, including waist circumference, fasting glucose, and insulin (12,13,39).”
BackgroundMetabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients
Rogers, A. J., McGeachie, M., Baron, R. M., Gazourian, L., Haspel, J. A., Nakahira, K., Fredenburgh, L. E., Hunninghake, G. M., Raby, B. A., Matthay, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087538 · Cited by 178
“[6,7] Finally, metabolomic profiling has been performed in multiple complex trait diseases (notably recent work in cancer [8], diabetes [9], tuberculosis [10] and, most recently, septic shock in children [11]), in each case identifying important novel biologic pathways that contribute to pathogenesis and prognosis.”
BackgroundLipidomics of familial longevity
Gonzalez‐Covarrubias, V., Beekman, M., Uh, H., Dane, A., Troost, J., Paliukhovich, I., van der Kloet, F. M., Houwing‐Duistermaat, J., Vreeken, R. J., Hankemeier, T., et al. (2013) · Aging Cell · doi:10.1111/acel.12064 · Cited by 176
“Molecular characterization of triglyceride and sphingomyelin species has identified specific lipids underlying insulin resistance (Suhre et al., 2010; Rhee et al., 2011), Alzheimer’s (Han et al.”
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
Kowalski, G. M., Carey, A. L., Selathurai, A., Kingwell, B. A., & Bruce, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072449 · Cited by 175
“While this approach has been useful, recently there has been an emergence of research attempting to identify other circulating lipid species that may prove to be more accurate biomarkers of disease onset and progression [4–7].”
BackgroundGenetic architecture of human plasma lipidome and its link to cardiovascular disease
Tabassum, R., Rämö, J. T., Ripatti, P., Koskela, J. T., Kurki, M., Karjalainen, J., Palta, P., Hassan, S., Nunez-Fontarnau, J., Kiiskinen, T. T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11954-8 · Cited by 175
Jian, H., Liu, Y., Wang, X., Dong, X., & Zou, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043900 · Cited by 173
A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes
Park, S., Sadanala, K. C., & Kim, E.-K. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0126 · Cited by 168
“…involved in disease mechanisms by observing metabolite level variations in diseased individuals in comparison with healthy ones (Cheng et al., 2012; Goek et al., 2012; Newgard et al., 2009; Pietiläinen et al., 2007; Rhee et al., 2011; Shaham et al., 2008; Wang et al., 2011; Zhao et al., 2010).”
BackgroundMetabolomics and Diabetes: Analytical and Computational Approaches
Sas, K. M., Karnovsky, A., Michailidis, G., & Pennathur, S. (2015) · Diabetes · doi:10.2337/db14-0509 · Cited by 168
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P., Nygren, H., Arola, J., Castillo, S., Mattila, I., Hakkarainen, A., Borra, R. J. H., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 167
“This may explain the recent finding from a prospective study that more saturated TGs and those with shorter acyl chains associate with a higher risk of developing type 2 diabetes [38], as NAFLD both precedes and predicts type 2 diabetes [4].”
BackgroundPlatelet Lipidomics: Modern Day Perspective on Lipid Discovery and Characterization in Platelets
O’Donnell, V. B., Murphy, R. C., & Watson, S. P. (2014) · Circulation Research · doi:10.1161/circresaha.114.301597 · Cited by 166
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease
Pereira, P. R., Carrageta, D. F., Oliveira, P. F., Rodrigues, A., Alves, M. G., & Monteiro, M. P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21883 · Cited by 166
“Among those, lipids and amino acids are the most extensively studied as both elevated saturated chain triglycerides (TAGs) and related lipotoxicity and elevated levels of serum branched‐chain amino acids (BCAAs) and aromatic amino acids highlight a higher risk of developing type 2 diabetes.(46,47) DKD is one of the mo…”
BackgroundType 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
Rusu, V., Hoch, E., Mercader, J. M., Tenen, D. E., Gymrek, M., Hartigan, C. R., DeRan, M., von Grotthuss, M., Fontanillas, P., Spooner, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.011 · Cited by 152
“…Mihalik et al., 2010), (2) DAGs are associated with hepatic and skeletal muscle insulin resistance (Erion and Shulman, 2010), and (3) TAG accumulation in liver and plasma is associated with diabetic insulin resistance and T2D (Rhee et al., 2011; Samuel and Shulman, 2012; Seymour and Byrne, 1993).”
BackgroundSelf-citationDistinct metabolomic signatures are associated with longevity in humans
Cheng, S., Larson, M. G., McCabe, E. L., Murabito, J. M., Rhee, E. P., Ho, J. E., Jacques, P. F., Ghorbani, A., Magnusson, M., Souza, A. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7791 · Cited by 161
“13, 14, 65 For all 3 profiling platforms, a pooled plasma sample was also run following every 20 samples, and the peak areas in samples were normalized to metabolite peak areas in the nearest pooled plasma.”
Self-citationBird, S. S., Marur, V. R., Sniatynski, M. J., Greenberg, H. K., & Kristal, B. S. (2011) · Analytical Chemistry · doi:10.1021/ac201195d · Cited by 159
Metabolite Profiles During Oral Glucose Challenge
Ho, J. E., Larson, M. G., Vasan, R. S., Ghorbani, A., Cheng, S., Rhee, E. P., Florez, J. C., Clish, C. B., Gerszten, R. E., & Wang, T. J. (2013) · Diabetes · doi:10.2337/db12-0754 · Cited by 157
“Similarly, lipid profiling has demonstrated novel perturbations in triacylglycerol distribution that signal future diabetes risk (4).”
BackgroundSelf-citationPharmacotherapy of type 2 diabetes: An update and future directions
DeMarsilis, A. J., Reddy, N., Boutari, C., Filippaios, A., Sternthal, E., Katsiki, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155332 · Cited by 184
The circulating metabolome of human starvation
Steinhauser, M. L., Olenchock, B. A., O’Keefe, J., Lun, M., Pierce, K. A., Lee, H., Pantano, L., Klibanski, A., Shulman, G. I., Clish, C. B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121434 · Cited by 152
“species defined by carbon content and carbon-carbon double bond number (degree of unsaturation) (15).”
BackgroundInfluentialSelf-citationMontoliu, I., Scherer, M., Beguelin, F., DaSilva, L., Mari, D., Salvioli, S., Martin, F.-P. J., Capri, M., Bucci, L., Ostan, R., et al. (2014) · Aging · doi:10.18632/aging.100630 · Cited by 150
“While usually highly unsaturated TG are target to peroxidation and the overall triglycerides family are seen as an adverse risk factor, recent investigations points to specific TG linked to adverse events where lipids of higher carbon number and double bond content were associated with decreased risk [48].”
BackgroundSex, gut microbiome, and cardiovascular disease risk
Razavi, A. C., Potts, K. S., Kelly, T. N., & Bazzano, L. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0240-z · Cited by 168
“Serum triglycerides [66], membrane phospholipids [67], and branched-chain amino acids (BCAAs) [68] are associated with insulin resistance and type II diabetes.”
BackgroundLipidome as a predictive tool in progression to type 2 diabetes in Finnish men
Suvitaival, T., Bondia-Pons, I., Yetukuri, L., Pöhö, P., Nolan, J. J., Hyötyläinen, T., Kuusisto, J., & Orešič, M. (2018) · Metabolism · doi:10.1016/j.metabol.2017.08.014 · Cited by 146
“[18] Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al.”
BackgroundResultLu, J., Lam, S. M., Wan, Q., Shi, L., Huo, Y., Chen, L., Tang, X., Li, B., Wu, X., Peng, K., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0100 · Cited by 148
“We identified far more TAGs associated with increased risk of T2DM than other studies, including FHS (9), European Prospective Investigation into Cancer and Nutrition (EPIC) (10), and PREDIMED (17) (Supplementary Table 3), which may be due to the differences in population characteristics, analytical platform used, and…”
BackgroundResultInfluentialDrogan, D., Dunn, W. B., Lin, W., Buijsse, B., Schulze, M. B., Langenberg, C., Brown, M., Floegel, A., Dietrich, S., Rolandsson, O., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.228965 · Cited by 150
Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila
Musselman, L. P., Fink, J. L., Ramachandran, P. V., Patterson, B. W., Okunade, A. L., Maier, E., Brent, M. R., Turk, J., & Baranski, T. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371047 · Cited by 144
“Recent work describing the TAG signature of insulin resistance in humans associated increased risk with reduced carbon chain length and double bond content (68).”
BackgroundVijayakumar, A., Aryal, P., Wen, J., Syed, I., Vazirani, R. P., Moraes-Vieira, P. M., Camporez, J. P., Gallop, M. R., Perry, R. J., Peroni, O. D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.091 · Cited by 143
“A metabolic signature of increased fatty acid desaturation (monounsaturated to saturated fatty acid ratio) and elongation is associated with insulin sensitivity in humans and rodents (Benhamed et al., 2012; Rhee et al., 2011).”
BackgroundMerino, J., Leong, A., Liu, C.-T., Porneala, B., Walford, G. A., von Grotthuss, M., Wang, T. J., Flannick, J., Dupuis, J., Levy, D., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4599-x · Cited by 144
“TAGs with lower carbon number or 2-aminoadipate [12, 14]) are likely to be relevant even before initial glycaemic perturbations.”
Self-citationPolyunsaturated Fatty Acid Desaturation Is a Mechanism for Glycolytic NAD+ Recycling
Kim, W., Deik, A., Gonzalez, C., Gonzalez, M. E., Fu, F., Ferrari, M., Churchhouse, C. L., Florez, J. C., Jacobs, S. B. R., Clish, C. B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.023 · Cited by 143
“Using an earlier iteration of the platform utilized herein, we profiled plasma from individuals before and after oral glucose tolerance testing, oral sulfonylurea administration, and exercise treadmill testing (Rhee et al., 2011), using each individual as his or her own biologic control.”
InfluentialSelf-citationThe relationship between phospholipids and insulin resistance: From clinical to experimental studies
Chang, W., Hatch, G. M., Wang, Y., Yu, F., & Wang, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13984 · Cited by 154
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Plasma Lipid Composition and Risk of Developing Cardiovascular Disease
Fernandez, C., Sandin, M., Sampaio, J. L., Almgren, P., Narkiewicz, K., Hoffmann, M., Hedner, T., Wahlstrand, B., Simons, K., Shevchenko, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071846 · Cited by 141
“Lipidomic analyses for human biomarker discovery using either approach are now emerging [8–10].”
Gaike, A. H., Paul, D., Bhute, S. S., Dhotre, D. P., Pande, P., Upadhyaya, S., Reddy, Y. B. S., Sampath, R., Ghosh, D., Chandraprabha, D., et al. (2020) · mSystems · doi:10.1128/msystems.00578-19 · Cited by 155
Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity
Zhu, L., Martinez, M. N., Emfinger, C. H., Palmisano, B. T., & Stafford, J. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00579.2013 · Cited by 130
A Plasma Long‐Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients
Kalim, S., Clish, C. B., Wenger, J., Elmariah, S., Yeh, R. W., Deferio, J. J., Pierce, K. A., Deik, A., Gerszten, R. E., Thadhani, R., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000542 · Cited by 137
Self-citationPhenotypic flexibility as a measure of health: the optimal nutritional stress response test
Stroeve, J. H. M., van Wietmarschen, H., Kremer, B. H. A., van Ommen, B., & Wopereis, S. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0459-1 · Cited by 126
“TGs of lower carbon number and double-bond content decreased 2 h after glucose intake, while TGs of higher carbon number and double-bond content increased (Rhee et al. 2011).”
BackgroundInfluentialCold-induced lipid dynamics and transcriptional programs in white adipose tissue
Xu, Z., You, W., Zhou, Y., Chen, W., Wang, Y., & Shan, T. (2019) · BMC Biology · doi:10.1186/s12915-019-0693-x · Cited by 125
Walford, G. A., Ma, Y., Clish, C., Florez, J. C., Wang, T. J., Gerszten, R. E., & for the Diabetes Prevention Program Research Group (2016) · Diabetes · doi:10.2337/db15-1063 · Cited by 125
“Metabolite profiling was performed as previously described (2,7,8).”
Self-citationChouraki, V., Preis, S. R., Yang, Q., Beiser, A., Li, S., Larson, M. G., Weinstein, G., Wang, T. J., Gerszten, R. E., Vasan, R. S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.009 · Cited by 126
Self-citationMetabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations
Leoni, V., Strittmatter, L., Zorzi, G., Zibordi, F., Dusi, S., Garavaglia, B., Venco, P., Caccia, C., Souza, A. L., Deik, A., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.12.005 · Cited by 124
Self-citationFerguson, J. F., Allayee, H., Gerszten, R. E., Ideraabdullah, F., Kris-Etherton, P. M., Ordovás, J. M., Rimm, E. B., Wang, T. J., & Bennett, B. J. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/hcg.0000000000000030 · Cited by 123
“pathogenic in cardiometabolic disease, triacylglycerols with long-chain PUFAs are thought to be protective.(182) However,”
Self-citationAfshinnia, F., Nair, V., Lin, J., Rajendiran, T. M., Soni, T., Byun, J., Sharma, K., Fort, P. E., Gardner, T. W., Looker, H. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130317 · Cited by 122
Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation
Eichelmann, F., Sellem, L., Wittenbecher, C., Jäger, S., Kuxhaus, O., Prada, M., Cuadrat, R. R. C., Jackson, K. G., Lovegrove, J. A., & Schulze, M. B. (2022) · Circulation · doi:10.1161/circulationaha.121.056805 · Cited by 130
Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
Scholtens, D. M., Muehlbauer, M. J., Daya, N. R., Stevens, R. D., Dyer, A. R., Lowe, L. P., Metzger, B. E., Newgard, C. B., Bain, J. R., Lowe, W. L., et al. (2014) · Diabetes Care · doi:10.2337/dc13-0989 · Cited by 117
“More recent cohort and/or population-based studies have demonstrated association of BCAA levels with insulin resistance, higher glucose levels, and changes in insulin resistance and glucose homeostasis after weight loss (21,25,26,28,29), while higher levels of BCAAs are present in type 2 diabetic subjects compared wit…”
BackgroundMetabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 129
Tong, B., Ba, Y., Li, Z., Yang, C., Su, K., Qi, H., Zhang, D., Liu, X., Wu, Y., Chen, Y., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106505 · Cited by 117
“Triacylglycerols and very low-density lipoproteins, as two markers of lipid metabolism, have been flagged as likely contributors to diminished insulin sensitivity based on their metabolic profiles (Rhee et al., 2011).”
BackgroundWopereis, S., Stroeve, J. H. M., Stafleu, A., Bakker, G. C. M., Burggraaf, J., van Erk, M. J., Pellis, L., Boessen, R., Kardinaal, A. A. F., & van Ommen, B. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0570-6 · Cited by 129
Metadata
- Authors
- Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E.
- Affiliations
- Broad Institute (US)
- Boston University (US)
- Massachusetts General Hospital (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1402-1411
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069773
- OpenAlex
- W2169156123
- Cited by
- 647
- References
- 33
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 48 · 2023: 54 · 2022: 65 · 2021: 57 · 2020: 52 · 2019: 47 · 2018: 38 · 2017: 41 · 2016: 44 · 2015: 33 · 2014: 40 · 2013: 45 · 2012: 25
- FWCI
- 31.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation (N01-HC-25195)
- Donald W. Reynolds Foundation
- American Heart Association (N01-HC-25195)
- Endocrine Fellows Foundation
- Fondation Leducq
- National Institutes of Health (n01hc025195-11-0-0, N01-HC 25195)
- National Heart, Lung, and Blood Institute (N01‐HC25195, R01HL081572, N01-HC-025195, K23HL091106)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088214, T32-DK-00754023, T32DK007540, R01-DK-HL-081572, R01DK081572)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- type 2 diabetes, insulin resistance, triglycerides, lipidomics, plasma lipids, acyl chain length, double bond content, dyslipidemia, diabetes risk prediction, oral glucose tolerance test, insulin action, acute exercise
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Exercise Test, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Molecular Structure, Biomarkers, Case-Control Studies, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.